New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 88% Response Rate
Send Enquiry
Product Brochure
| Strength | 260 mg |
| Pack Size | 43.4 ml |
| Pack Type | Vial |
| Manufacturer | Biological E Ltd |
| Country of Origin | Made in India |
| Salt Composition | Paclitaxel 260mg Injection |
View Complete details
Product Brochure
| Strength | 30 mg |
| Pack Size | 5 ml |
| Pack Type | Vial |
| Manufacturer | Biological E Ltd |
| Country of Origin | Made in India |
| Salt Composition | Paclitaxel 30mg Injection |
View Complete details
Product Brochure
| Strength | 250 mg |
| Packaging Size | 5ml |
| Manufactured By | Biocon Ltd |
| Country of Origin | Made in India |
| Salt Composition | Fulvestrant 250mg Injection |
| Prescription/Non-Prescription | Prescription |
Fasnorm 250mg Injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body.
Do not take this injection if you are allergic to Fasnorm 250mg Injection or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fasnorm 250mg Injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.
Common side effects of Fasnorm 250mg Injection are pain or inflammation at the site of injection, abnormal levels of liver enzymes, nausea, headache, cough, weakness or tiredness, joint and muscle pain, hot flashes, hair loss, and skin rash. Your doctor may advise you to take certain blood tests while receiving this injection. This injection may increase your risk of bleeding and liver failure. Female patients of reproductive potential should use effective contraception during treatment with this injection and for two years after the last dose.
View Complete details
Product Brochure
| Strength | 60 mg/1.5 ml |
| Packaging Size | 1.5 ml Vial |
| Packaging Type | Vial |
| Prescription/Non prescription | Prescription |
| Country of origin | Made in India |
| Salt Composition | Cabazitaxel 60mg Injection |
| Manufacturer | Zee Laboratories Ltd |
Zevtaxel 60mg Injection contains the active constituent cabazitaxel. It is an anticancer medicine used with steroid medicine prednisone or prednisolone to treat people with hormone-refractory metastatic prostate cancer that has progressed after treatment with other anticancer medications, including docetaxel. Cancer is an abnormal and uncontrolled multiplication of cells. Many early-stage prostate cancers need normal testosterone (male hormone) levels to grow. In hormone-refractory metastatic prostate cancer, cancer keeps growing even when the amount of testosterone in the body is reduced to low levels. This medicine should not be used if you have a severe abnormal liver function or have recently been vaccinated against yellow fever.
Its major toxicities include myelosuppression, neurotoxicity, and allergic reactions. Neutropenia is the most common adverse reaction to this drug. Monitoring of complete blood counts is essential on a weekly basis during cycle 1 and before each treatment cycle thereafter so that the dose can be adjusted, if needed. Vaccination with a live attenuated vaccine should be avoided in patients receiving the medicine, instead killed or inactivated vaccines can be administered.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. This drug is unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this drug. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.
View Complete details
Product Brochure
| Packaging Size | 1X0.6 ml Vial |
| Strength | 6 mg/ 0.6 ml |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Salt Composition | Peg-Gcsf 6mg (Pegfilgrastim) Injection |
| Country of Origin | India |
| Manufacturer | Emcure Pharmaceuticals Ltd |
Pegex 6mg Injection contains the active ingredient Pegfilgrastim. It belongs to the class granulocyte colony stimulated factor approved by FDA to decrease the risk of developing febrile neutropenia ( occurrence of fever or infection with low WBC count) and the duration of neutropenia (Low white blood cell count) when receiving bonemarrow suppressive chemotherapy drugs. It is also indicated to increase survival rate in patients exposed to radiation therapy which can cause severe and life-threatening damage to bone marrow. It acts on blood-forming cells, thereby stimulating cell multiplication and cell function activation.
Pegfilgrastim is a protein synthesized through biotechnology in E. coli bacteria. It belongs to the cytokine family of proteins and is very similar to a natural protein (granulocyte-colony stimulating factor) produced by your body. White blood cells (WBC) are important because they help your body fight infection. These cells are highly sensitive to the effects of chemotherapy, which might cause a decrease in the number. If your WBC decreases, your body may not have enough cells to combat bacteria, putting you at risk of infection.
Inform your physician if you have or ever had liver disease, fever or infection, kidney problems, heart problems, or a family history of kidney diseases before starting the treatment with this Injection. Do not take this Injection if you are allergic to pegfilgrastim. Filgrastim or any of the other ingredients in this Injection. Report any symptoms of left upper abdominal pain, shoulder pain, and respiratory problems immediately to your doctor. The most common side effects of Pegex 6mg injection are pain in the bones, arms, and legs.
View Complete details
Product Brochure
| Strength | 440 mg |
| Packaging Size | 20ml |
| Packaging Type | Box |
| Manufactured By | Abbott Healthcare Pvt. Ltd. |
| Usage | Hospital |
| Salt Composition | Trastuzumab 440mg Injection |
| Country of Origin | India |
Priunta 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.
Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.
Priunta 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.
View Complete details
Product Brochure
| Strength | 30 mg |
| Packaging Type | Box |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Shelf Life | 36 Months |
| Prescription/Non-Prescription | Prescription |
| Country of Origin | Made in India |
| Salt Composition | Octreotide 30mg Injection |
Somalinx injection also available in 20mg
Somalinx 30mg injection contains the active substance octreotide. It is a synthetic compound derived from somatostatin, a substance naturally found in the human body that inhibits the effects of certain hormones, such as growth hormones. It is used to reduce the amount of growth hormone produced by people with acromegaly (a condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who cannot be treated with surgery, radiation, or another medication.
It is also used to control diarrhea and flushing caused by carcinoid tumors (slow-growing tumors that release natural substances that can cause symptoms) and vasoactive intestinal peptide-secreting adenomas (VIP-omas; tumors that form in the pancreas and release natural substances that can cause symptoms). It is used to prevent complications following surgery of the pancreas gland. It is also indicated to stop bleeding and to protect from re-bleeding from ruptured gastro-esophageal varices in patients suffering from chronic liver disease. This medicine is used to treat people with pituitary tumors that produce too much thyroid-stimulating hormone (TSH) when other types of treatment (surgery or radiotherapy) are not suitable or have not worked and after radiotherapy, to cover the interim period until the radiotherapy becomes fully effective.
Do not use this medicine if you are allergic to octreotide or any of the other ingredients of this medicine. Inform your physician if you have gallstones, high or low blood sugar levels, vitamin B12 deficiency, and liver diseases. Somalinx 30mg injection may lower your heart rate, and very high doses can cause abnormal heart rhythm, so your doctor may monitor your heart function regularly during the treatment. Inform your physician if you are pregnant or breastfeeding before initiating the treatment.
View Complete details
Product Brochure
| Strength | 150 mg |
| Packaging Size | 7.2 ml |
| Packaging Type | Vial |
| Manufactured By | Abbott Healthcare Pvt. Ltd. |
| Usage | Hospital |
| Salt Composition | Trastuzumab 150mg Injection |
| Country of Origin | India |
Eleftha150mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.
Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.
Eleftha150mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.
View Complete details
Product Brochure
| Dose/ Strength | 50 mg/5 ml |
| Packaging Type | Vial |
| Manufactured By | Samarth Life Sciences Pvt Ltd |
| Country of Origin | Made in India |
| Salt Composition | Leucovorin Calcium 50mg Injection |
| Prescription/Non prescription | prescription |
Leucorin 50mg Injection contains the active substance Leucovorin calcium which is chemically related to a vitamin called folic acid. It belongs to the class folic acid analogs. It is used to prevent the harmful effects of methotrexate medicine when treating certain types of cancer. It is also used to treat people who have accidentally overdosed on methotrexate medicine or medications that belong to a similar class. It is also used with other anticancer medications to treat colorectal cancer (cancer that begins in the colon or rectum). Other uses include treating anemia caused by low levels of folic acid in the body.
Do not take Leucorin 50mg Injection if you are allergic to Leucovorin calcium, calcium folinate, or any other ingredients of this medicine if you have certain types of anemia (pernicious anemia or megaloblastic anemia) where vitamin B12 is deficient. Before initiating the treatment, inform your physician if you have anemia, kidney, heart, or liver problems. Inform your physician if you are using any medications for treating seizures. Notify your physician if you face any symptoms of wheezing or trouble breathing, skin rash, itching or hives, or swelling in the lips, face, or tongue.
View Complete details
Product Brochure
| Strength | 500 mg |
| Packaging Type | Vial |
| Packaging Size | 50 ml |
| Manufacturer | Reliance Life Sciences Pvt Ltd |
| Country of Origin | Made in India |
| Salt Composition | Rituximab 500mg Injection |
Rituxirel 500mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the leukapheresis body cells of its own joints) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.
Rituxirel 500mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Rituxirel 500mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.
View Complete details
Product Brochure
| Strength | 100 mg |
| Packaging Type | Vial |
| Packaging Size | 10 ml |
| Manufacturer | Reliance Life Sciences Pvt Ltd |
| Country of Origin | Made in India |
| Salt Composition | Rituximab 100mg Injection |
Rituxirel 100mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the leukapheresis body cells of its own joints) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.
Rituxirel 100mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Rituxirel 100mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.
View Complete details
Product Brochure
| Dose/Strength | 60 mg |
| Packaging Size | 1 ml |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Salt Composition | Denosumab 60mg Injection |
| Manufacturer | Intas Pharmaceuticals Ltd |
Olimab Injection 60mg consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. Olimab injection uses in prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Olimab 60mg Injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment. Olimab 60 mg injection can be used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures.
Olimab 60mg Injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
View Complete details
Product Brochure
| Dose/Strength | 2 mg |
| Packaging Type | Vial |
| Manufactured By | Cadila Pharmaceuticals Ltd |
| Usage/Application | Hospital |
| Salt Composition | Bortezomib 2mg Injection |
| Country of Origin | India |
Bortecad 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.
The common side effects likely associated with Bortecad 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.
Inform your doctor if you are allergic to Bortecad 2mg Injection and its ingredients. Do not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Inform your doctor of diabetes because this Injection can affect your blood glucose levels.
View Complete details
Product Brochure
| Dose/Strength | 2.5 mg |
| Packaging Type | Vial |
| Manufactured By | Cadila Pharmaceuticals Ltd |
| Usage/Application | Hospital |
| Salt Composition | Bortezomib 2.5mg Injection |
| Country of Origin | India |
Bortecad 2.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.
The common side effects likely associated with Bortecad 2.5mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.
Inform your doctor if you are allergic to Bortecad 2.5mg Injection and its ingredients. Do not use this medication if you have severe lung or heart problems. Before starting treatment with this medication, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Inform your doctor of diabetes because this Injection can affect your blood glucose levels.
View Complete details
Product Brochure
| Strength | 22.5 mg |
| Packaging Type | Vial |
| Salt Composition | Leuprolide Acetate 22.5mg Injection |
| Manufacturer | Metta Life Sciences Pvt Ltd |
| Country of Origin | India |
| Prescription/Non-Prescription | Prescription |
Trudepot 22.5mg Injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists. Trudepot 22.5mg Injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it) and uterine fibroids (noncancerous growths of the uterus) in women.
This medicine is also used in treating premature puberty (central precocious puberty); due to certain hormonal releases, a child’s body begins to change into an adult at an early age.
It is not recommended to take this if you are allergic to Leuprolide acetate or any other ingredients, including Goserelin and Triptorlin of the medicine and products relating to gonadotropin-releasing hormone (GnRH). During the treatment, the existing symptoms may worsen due to the initial sex steroid increase in the body. This will subside after the continual use of the medicine. Talk to your physician for more concerns.
This medicine is not recommended in pregnant and breastfeeding women and patients with abnormal vaginal bleeding. It is not recommended if you experience abnormal vaginal bleeding. It is not recommended for use if you experience seizure or mood disorders. Men who experience urinary blockage or who have undergone testicular excision should inform their physician.
It is advised to measure bone density at regular intervals. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Trudepot 22.5mg Injection. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).
Inform your doctor about any underlying medical disorders you may have before beginning therapy, such as diabetes, seizures, heart problems including chest pain, irregular heartbeats, depression, or an increased risk of osteoporosis (thinning of the bones). It is advised to inform your healthcare professional about all the medicines you are taking, including prescription, over-the-counter, herbal and vitamin supplements, before starting the therapy.
View Complete details
Product Brochure
| Strength | 3.75 mg |
| Packaging Type | Vial |
| Salt Composition | Leuprolide Acetate 3.75mg Injection |
| Manufacturer | Bharat Serums & Vaccines Ltd |
| Prescription/Non-Prescription | Prescription |
| Country of Origin | India |
Leuprolyn Depot 3.75mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.
Do not receive this injection if you are allergic to Leuprolyn Depot 3.75mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.
Before starting the treatment, notify your doctor about your underlying medical conditions, such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or are at increased risk of thinning of bones (osteoporosis). This medicine is not recommended for patients with abnormal vaginal bleeding. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Leuprolyn Depot 3.75mg injection. Report to your doctor if you are a man with urinary obstruction or had an operation to remove your testicles. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).
View Complete details
Product Brochure
| Strength | 40 mcg |
| Pack Size | 0.40 ml |
| Pack Type | Vial |
| Manufacturer | Dr Reddy'S Laboratories Ltd |
| Salt Composition | Darbepoetin Alfa 40mcg Injection |
| Country of Origin | India |
| Prescription/Non-Prescription | Prescription |
Cresp 40 injection composition contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.
Do not take Inj Cresp 40 mcg if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.
If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 40mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough. You can get cresp 40 mcg injection online but the price is based on the location and seller.
View Complete details
Product Brochure
| Strength | 60 mcg |
| Pack Size | 0.3 ml |
| Pack Type | Vial |
| Manufacturer | Dr Reddy'S Laboratories Ltd |
| Salt Composition | Darbepoetin Alfa 60mcg Injection |
| Country of Origin | India |
A 60mcg injection of Cresp contains the active ingredient Darbepoetin Alfa. It is an erythropoiesis-stimulating agent (ESA) that belongs to the class of medications called hematopoietic growth factors. It is used to treat anaemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anaemia caused by chemotherapy in people with certain types of cancer. The symptoms of anaemia are fatigue, weakness, and shortness of breath.
Do not take Cresp 60mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anaemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.
If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking the Cresp 60mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.
View Complete details
Product Brochure
| Dose/Strength | 4 mg |
| Packaging Type | Vial |
| Manufacturer | Natco Pharma Ltd |
| Usage/Application | Hospital |
| Salt Composition | Zoledronic Acid 4mg Injection |
| Prescription/Non-Prescription | Prescription |
Zoldonat 4mg Injection contains the active substance Zoledronic Acid. It belongs to the group of substances called bisphosphonates. It is used to reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumor. Tumors can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumor-induced hypercalcemia (TIH). It is also used to prevent bone complications in adult patients with multiple myeloma and bone metastases from solid tumors (spread of cancer from the primary site to the bone), in addition to standard cancer therapy.
Zoldonat 4mg Injection is also indicated to prevent or treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause. It is also used to treat osteoporosis in men. It is used to treat Paget’s disease of bone (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken). Other uses include treating or preventing osteoporosis in men and women taking glucocorticoids (a corticosteroid medication that may cause osteoporosis).
Do not take this injection if you are allergic to zoledronic acid, another bisphosphonate, or any other ingredients of this medicine and if you are pregnant or breastfeeding. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, pain, swelling, or jaw numbness. This medicine is not recommended for use in adolescents and children below the age of 18 years. Zoldonat 4mg Injection is not cancer chemotherapy and will not slow or stop the spread of cancer. However, it can be used to treat bone diseases in patients with cancer.
View Complete details
Product Brochure
| Strength | 100 mg |
| Packaging Type | Vial |
| Salt Composition | Azacitidine 100mg Injection |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Country of Origin | India |
| Prescription/Non-Prescription | Prescription |
View Complete details
Product Brochure
| Strength | 200 mg |
| Form | Tablet |
| Salt Composition | Azacitidine 200mg Tablets |
| Manufacturer | Zydus Lifescience Ltd. |
| Country of Origin | India |
| Packing Size | 14 Tablet(s) In A Bottle |
Azatend-O 200mg tablet consists of the active ingredient Azacitidine. It is used for treating adults with blood conditions, namely Myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia, and Acute myeloid leukemia (AML), if they are considered ineligible for stem cell transplant.
In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer caused by the release of incompletely formed blood cells into the bloodstream. Chronic myelomonocytic leukemia is a rare form of blood cancer caused by an increased number of monocytes of the white blood cells.
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Azatend-O 200mg tablet and cause undesirable side effects.
View Complete details
Product Brochure
| Strength | 100 mg |
| Pack Size | 16.7 ml |
| Pack Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Country of Origin | Made in India |
| Salt Composition | Paclitaxel 100mg Injection |
View Complete details
Product Brochure
| Strength | 25 mcg |
| Pack Size | 0.42 ml |
| Pack Type | Vial |
| Manufacturer | Dr Reddy'S Laboratories Ltd |
| Salt Composition | Darbepoetin Alfa 25mcg Injection |
| Prescription/Non-Prescription | Prescription |
Cresp 25mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.
Do not take Cresp 25mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.
If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking the Cresp 25mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.
View Complete details
Product Brochure
| Strength | 500 mcg |
| Pack Size | 1 ml |
| Pack Type | Vial |
| Manufacturer | Dr Reddy'S Laboratories Ltd |
| Salt Composition | Darbepoetin Alfa 500mcg Injection |
| Prescription/Non-Prescription | Prescription |
Cresp 500mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.
Do not take Cresp 500mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.
If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Cresp 500mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.
View Complete details
Product Brochure
| Strength | 200 mcg |
| Pack Size | 0.40 ml |
| Pack Type | Vial |
| Manufacturer | Dr Reddy'S Laboratories Ltd |
| Salt Composition | Darbepoetin Alfa 200mcg Injection |
| Prescription/Non-Prescription | Prescription |
Zynesp 200mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.
Do not take Zynesp 200mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.
If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Zynesp 200mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.
View Complete details
Product Brochure
| Dose/Strength | 1000 mg |
| Packaging Type | Vial |
| Manufacturer | Emcure Pharmaceuticals Ltd. |
| Usage/Application | Hospital |
| Salt Composition | Gemcitabine 1gm Injection |
| Country of Origin | India |
View Complete details
Product Brochure
| Strength | 150 mg/15ml |
| Pack Size | 15 ml |
| Pack Type | Vial |
| Manufacturer | Therdose Pharma Pvt Ltd |
| Salt Composition | Carboplatin 150mg Injection |
| Country of Origin | India |
View Complete details
Product Brochure
| Strength | 450 mg/45ml |
| Pack Size | 45 ml |
| Pack Type | Vial |
| Manufacturer | Wembrace Biopharma Pvt Ltd |
| Salt Composition | Carboplatin 450mg Injection |
| Country of Origin | India |
Carbowemb 450mg injection belongs to the medication class known as an alkylating agent. It is an anti-cancer medicine that contains the active ingredient Carboplatin. It treats a certain type of ovarian and lung cancer as a single or combined with other medications.
Consult your doctor if you have any symptoms of allergic reactions, abnormal bruises, kidney problems (haemolytic-uraemic syndrome), and a decrease in red blood cells (anemia). Report to your doctor if you experience any lung-related symptoms like; shortness of breath, lung tissue inflammation, or lung infection while taking Carbowemb 450mg injection.
Use effective contraception while receiving this medication and continue to use it for six months, even after receiving the final dose. Carbowemb 450mg injection medicine may reduce fertility temporarily or permanently in both men and women. So it is advised to get suggestions about fertility concerns from your doctor.
View Complete details
Product Brochure
| Strength | 120 mg |
| Pack Size | 6 ml |
| Pack Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Country of Origin | Made in India |
| Salt Composition | Docetaxel 120mg Injection |
View Complete details
Product Brochure
| Strength | 80 mg |
| Pack Size | 4ml |
| Pack Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Country of Origin | Made in India |
| Salt Composition | Docetaxel 80mg Injection |
View Complete details
Product Brochure
| Strength | 20 mg |
| Pack Size | 1 ml |
| Pack Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Country of Origin | Made in India |
| Salt Composition | Docetaxel 20mg Injection |
View Complete details
Product Brochure
| Strength | 40 mg/ 2 ml |
| Packaging Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Salt Composition | Irinotecan 40mg Injection |
| Country of Origin | India |
| Prescription/Non Prescription | Prescription |
Iritero 40mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.
Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhea are the most common adverse effects of this medication. Other common side effects of Iritero 40 mg Injection are nausea, vomiting, abdominal pain, constipation, anemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist in you.
Inform your physician if you are allergic to Iritero 40 mg Injection and its ingredients. Before starting treatment, let your physician know if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Consult your healthcare provider if you take other medicines, herbs, and supplements. Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check for the effects of the medicine on blood counts or blood chemistry.
View Complete details
Product Brochure
| Dose/Strength | 100 mg /50 ml |
| Packaging Type | Vial |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Usage/Application | Hospital |
| Salt Composition | Oxaliplatin 100mg Injection |
| Country of Origin | India |
Oxa 100mg Injection belongs to the group of medications called platinum-based antineoplastic agents. It consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer after resectioning (surgical removal) of the primary tumor, metastatic colon and rectum cancer. It is used in combination with other anti-cancer medicines. Colorectal cancer is cancer that usually develops in the rectum and large intestine. It develops from the accumulation of various genetic mutations. Both environmental and genetic factors play a significant role in the origin of colorectal cancer. This medicine works against tumors that are resistant to cisplatin therapy.
The common side effects that are likely to associate with Oxa 100mg Injection are a reduced number of blood cells, unpleasant sensation in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, blood in urine, high blood pressure, depression, insomnia, low calcium level. Inform your doctor if these side effects disturb or persist in you.
Inform your doctor if you are allergic to Oxa 100mg Injection and its ingredients. Before starting treatment with this medication, inform your physician if you have moderate or mild kidney problems, liver problems, or heart disorders. Tell your doctor about all the medicines you are taking, including vaccinations. It is not recommended for pregnant and breastfeeding women.
View Complete details
Product Brochure
| Dose/Strength | 50 mg /25 ml |
| Packaging Type | Vial |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Usage/Application | Hospital |
| Salt Composition | Oxaliplatin 50mg Injection |
| Country of Origin | India |
Oxa 50mg Injection belongs to the group of medications called platinum-based antineoplastic agents. It consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer after resectioning (surgical removal) of the primary tumor, metastatic colon and rectum cancer. It is used in combination with other anti-cancer medicines. Colorectal cancer is cancer that usually develops in the rectum and large intestine. It develops from the accumulation of various genetic mutations. Both environmental and genetic factors play a significant role in the origin of colorectal cancer. This medicine works against tumors that are resistant to cisplatin therapy.
The common side effects that are likely to associate with Oxa 50mg Injection are a reduced number of blood cells, unpleasant sensation in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, blood in urine, high blood pressure, depression, insomnia, low calcium level. Inform your doctor if these side effects disturb or persist in you.
Inform your doctor if you are allergic to Oxa 50mg Injection and its ingredients. Before starting treatment with this medication, inform your physician if you have moderate or mild kidney problems, liver problems, or heart disorders. Tell your doctor about all the medicines you are taking, including vaccinations. It is not recommended for pregnant and breastfeeding women.
View Complete details
Product Brochure
| Strength | 80 mg |
| Packaging Type | Vial |
| Salt Composition | Degarelix 80mg Injection |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Country of Origin | India |
| Prescription/Non Prescription | Prescription |
Deghor 80mg injection contains the active ingredient degarelix. It is used to treat advanced prostate cancer. Prostate cancer is cancer that occurs in the prostate (a gland in males that produces seminal fluid). Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
Contact your doctor immediately if you experience dizziness, fever, or infection. During this treatment, your doctor may periodically monitor your blood pressure, blood sugar, electrolytes, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have been diagnosed with problems in your heart, liver, or kidneys. Patients with severe liver and kidney impairment should exercise caution while using this medicine. This medicine is contraindicated in patients with known hypersensitivity to this drug or to any of the product components. Deghor substitutes include other brands containing the same active ingredient, but should only be used under your doctor’s prescription.
Deghor 80mg injection has the potential to impair the fertility of males and females of reproductive potential. This injection is not recommended during pregnancy due to its ability to harm the foetus and cause miscarriage. It is not known if this medicine passes into breast milk. Consult your doctor for more advice. Possible side effects related to therapy include redness, swelling, and itching at the injection site. These are usually mild, self-limiting, and decrease within three days. Deghor price India varies by retailer and location.
View Complete details
Product Brochure
| Strength | 120 mg |
| Packaging Type | Vial |
| Salt Composition | Degarelix 120mg Injection |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Country of Origin | India |
| Prescription/Non Prescription | Prescription |
Deghor 120mg injection contains the active ingredient degarelix. It is used to treat advanced prostate cancer. Prostate cancer is cancer that occurs in the prostate (a gland in males that produces seminal fluid). Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
Contact your doctor immediately if you experience dizziness, fever, or infection. During this treatment, your doctor may periodically monitor your blood pressure, blood sugar, electrolytes, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have been diagnosed with problems in your heart, liver, or kidneys. Patients with severe liver and kidney impairment should exercise caution while using this medicine. This medicine is contraindicated in patients with known hypersensitivity to this drug or to any of the product components.
Deghor 120mg injection has the potential to impair the fertility of males and females of reproductive potential. This injection is not recommended during pregnancy due to its ability to harm the foetus and cause miscarriage. It is not known if this medicine passes into breast milk. Consult your doctor for more advice. Possible side effects related to therapy include redness, swelling, and itching at the injection site. These are usually mild, self-limiting, and decrease within three days.
View Complete details
Product Brochure
| Strength | 100 mg/5 ml |
| Packaging Type | Vial |
| Manufacturer | Hetero Healthcare Ltd |
| Salt Composition | Irinotecan Hydrochloride Trihydrate 100mg Injection |
| Country of Origin | India |
| Packing Size | 5 ml |
View Complete details
Product Brochure
| Strength | 50 mg |
| Packaging Type | Vial |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Usage | Hospital |
| Salt Composition | Fludarabine 50mg Injection |
| Country of Origin | India |
Fludara 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.
Fludara 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludara 50mg Injection.
View Complete details
Product Brochure
| Strength | 420 mg |
| Packaging Type | Vial |
| Salt Composition | Pertuzumab 420mg Injection |
| Manufacturer | Zydus Lifescience Ltd. |
| Country of Origin | India |
| Packing Size | 1 Vial(s) Of 14ml |
Sigrima 420mg Injection, is a targeted therapy containing the active constituents pertuzumab and trasrtuzumab. It is used to treat a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body (metastasized) or cancer that has come back after the treatment. It will also be given before or after the surgery if the cancer has not metastasized. Cancer occurs when cells begin to grow abnormally in an uncontrolled manner.
Before taking Sigrima 420mg Injection, talk to the physician if you have heart problems, have had radiotherapy, or have allergic conditions. This medication is not recommended for adolescents and children under 18. In patients with early-stage HER2-positive breast cancer, adding pertuzumab or trastuzumab to standard chemotherapy can reduce the risk of recurrence and improve disease-free survival.
View Complete details
Product Brochure
| Strength | 100 mg |
| Prescription/Non Prescription | Prescription |
| Country of Origin | Made in India |
| Salt Composition | Bendamustine 100mg Injection |
| Manufacturer | Miracalus Pharma Pvt. Ltd. |
| Packaging Type | Vial |
Xyotin 100mg Injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Bendamustine. It is used to prevent and treat chronic lymphocytic leukaemia (cancer of blood and bone marrow), non-Hodgkin’s lymphomas (cancer that forms in the lymph system, part of the immune system), and multiple myelomas (cancer of plasma cells, type of white blood cell).
The common side effects that are likely to occur with this medicine are headache, insomnia, fatigue, loss of appetite and rashes. Some serious side effects also include bone marrow suppression, tumor lysis syndrome, and Hepatotoxicity. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is often combined with rituximab, an immunotherapy drug, to treat various subtypes of non-Hodgkin's lymphoma, including follicular lymphoma, and mantle cell lymphoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. Consult your doctor immediately for more advice.
Treatment should not be started if your white blood cells (leukocytes) have fallen to counts below determined levels. Your doctor will determine these values at regular intervals. This medicine should not be used if you are allergic to this drug. If you are a man wanting to father a child, you should discuss the treatment with your physician, as taking this injection may reduce sperm production in men. This drug is typically given as an intravenous infusion over a period of 30-60 minutes. It is usually administered once every three to four weeks. Tell your physician about all the medications you have been taking recently, including herbal medicines and supplements, before taking Xyotin 100mg Injection.
View Complete details